Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome
- 9 February 2004
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (8) , 799-803
Abstract
Since 1988, 24 children have undergone haematopoietic stem cell transplantation (HSCT) for severe sickle cell disease (SCD) in our unit, 13 being grafted after having been exposed to hydroxyurea (HU) to control SCD-related complications. Different pre-transplant conditioning regimens were given over time: Bu14/Cy200 in six patients (group 1), Bu16/Cy200/antithymocyte globulin (ATG) in five (group 2) and Bu16/Cy200/ATG with HU prior to HSCT in 13 (group 3). The aim of this study is to compare the outcome after HSCT of these groups of patients, which differ according to pre-transplant drug exposure. Overall, 20 of the 24 transplanted children had stable engraftment and have remained free of SCD-related symptoms after HSCT; 19 of them are currently alive and cured of SCD. In group 1 (HU−, ATG−), we observed one unexplainable late death, one absent engraftment, one late rejection and one mixed stable chimerism. In group 2 (HU−, ATG+), we observed the absence of engraftment in two patients and one early rejection. In group 3 (HU+, ATG+), we observed no cases of either absent engraftment, mixed stable chimerism or late rejection. In our experience, pre-transplant treatment with HU seems to be associated with a lower incidence of rejection/absent engraftment in severe SCD patients. These results need to be confirmed with a larger number of patients.Keywords
This publication has 21 references indexed in Scilit:
- Related umbilical cord blood transplantation in patients with thalassemia and sickle cell diseaseBlood, 2002
- Stem Cell Transplantation for Sickle Cell Disease: Can We Reduce the Toxicity?Pediatric Pathology & Molecular Medicine, 2001
- Second marrow transplants for graft failure in patients with thalassemiaBone Marrow Transplantation, 1999
- Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in BelgiumBone Marrow Transplantation, 1998
- Three-Year Follow-Up of Hydroxyurea Treatment in Severely Ill Children with Sickle Cell DiseaseJournal of Pediatric Hematology/Oncology, 1997
- Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” AgentMedicine, 1996
- Clinical and hematologic effects of hydroxyurea in children with sickle cell anemiaThe Journal of Pediatrics, 1996
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Bone marrow transplant for sickle cell disease—the dilemmaBlood Reviews, 1993
- BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIAThe Lancet, 1988